Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hyatt Regency Bethesda

Sep 17, 2015 7:30 AM - Sep 18, 2015 3:15 PM

One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814-5326

Clinical Trial Disclosure & Data Transparency

Explore the impact of current and pending federal regulations on data transparency from industry, clinical, and regulatory perspectives’.

Session 2: ClinicalTrials.gov and EudraCT – An Update by NIH and EMA

Session Chair(s)

Robert  Paarlberg, MS

Robert Paarlberg, MS

Principal

Paarlberg & Associates LLC, United States

This session featuring representatives from NIH and EMA will provide an update on the requirements and status of ClinicalTrials.gov and EudraCT. The session will also have a panel for questions & answers.

Speaker(s)

Nicholas C. Ide, MS

Updates to the ClinicalTrials.gov Protocol Registration and Results System (PRS)

Nicholas C. Ide, MS

National Institutes of Health (NIH), United States

Chief Architect, ClinicalTrials.gov, National Library of Medicine

Rebecca  Williams, PharmD, MPH

Updates to the ClinicalTrials.gov Protocol Registration and Results System (PRS)

Rebecca Williams, PharmD, MPH

Essex, Part of Emmes Group, United States

Senior Clinical Trials Subject Matter Expert

Noemie  Manent, PharmD

Updates to the EudraCT Database

Noemie Manent, PharmD

European Medicines Agency, Netherlands

TDA-CTT Operations Workstream Lead

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.